Company

Royalty Pharma plc

RPRX · CIK 0001802768

SEC FORM 4

$5,621,692.38

Sale of 96,073 shares at $58.5148 per share.

Reporting Person Hite Christopher · Officer Title EVP & Chairman, Partnering · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001814238-26-000017 · filed 2026-09-24 · View filing →

SEC FORM 4

$231,402.79

Sale of 3,927 shares at $58.9261 per share.

Reporting Person Hite Christopher · Officer Title EVP & Chairman, Partnering · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001814238-26-000017 · filed 2026-09-24 · View filing →

SEC FORM 4

$5,997,250.00

Sale of 100,000 shares at $59.9725 per share.

Reporting Person Hite Christopher · Officer Title EVP & Chairman, Partnering · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001814238-26-000015 · filed 2026-08-19 · View filing →

SEC FORM 4

$540,752.47

Sale of 9,230 shares at $58.5864 per share.

Reporting Person Coyne Terrance P. · Officer Title EVP & CFO · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001814876-26-000027 · filed 2026-08-17 · View filing →

SEC FORM 4

$104,798.74

Sale of 1,772 shares at $59.1415 per share.

Reporting Person Coyne Terrance P. · Officer Title EVP & CFO · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001814876-26-000027 · filed 2026-08-17 · View filing →